We are engaging in therapies for the treatment of acne, impetigo, psoriasis, rosacea and atopic dermatitis and various forms of warts caused by human papillomavirus (HPV) as well as a novel soft tissue implant in preclinical development. Upon receipt of FDA clearance, we intend to commercialize the programs through our self-directed sales team focusing on practices using dermatology products.
Cutanea Life Sciences is engaged in clinical research studies. Read about current research study openings.
Cutanea Life Sciences, Inc.-sponsored clinical trials in patients are registered on ClinicalTrials.gov, a service of the U.S. National Institutes of Health.